132 related articles for article (PubMed ID: 15745806)
1. Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin.
Fylaktakidou KC; Lehn JM; Greferath R; Nicolau C
Bioorg Med Chem Lett; 2005 Mar; 15(6):1605-8. PubMed ID: 15745806
[TBL] [Abstract][Full Text] [Related]
2. myo-Inositol trispyrophosphate: a novel allosteric effector of hemoglobin with high permeation selectivity across the red blood cell plasma membrane.
Duarte CD; Greferath R; Nicolau C; Lehn JM
Chembiochem; 2010 Dec; 11(18):2543-8. PubMed ID: 21086482
[TBL] [Abstract][Full Text] [Related]
3. Synthesized allosteric effectors of the hemoglobin molecule: a possible mechanism for improved erythrocyte oxygen release capability in hemoglobinopathy H disease.
Papassotiriou I; Kister J; Griffon N; Abraham DJ; Kanavakis E; Traeger-Synodinos J; Stamoulakatou A; Marden MC; Poyart C
Exp Hematol; 1998 Sep; 26(10):922-6. PubMed ID: 9728926
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.
Kieda C; Greferath R; Crola da Silva C; Fylaktakidou KC; Lehn JM; Nicolau C
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15576-81. PubMed ID: 17028170
[TBL] [Abstract][Full Text] [Related]
5. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
Biolo A; Greferath R; Siwik DA; Qin F; Valsky E; Fylaktakidou KC; Pothukanuri S; Duarte CD; Schwarz RP; Lehn JM; Nicolau C; Colucci WS
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1926-9. PubMed ID: 19204295
[TBL] [Abstract][Full Text] [Related]
6. Polyphosphates and pyrophosphates of pentopyranoses and pentofuranoses as allosteric effectors of human hemoglobin: synthesis, molecular recognition, and oxygen release.
Fylaktakidou KC; Duarte CD; Jogireddy R; Koumbis AE; Nicolau C; Lehn JM
ChemMedChem; 2011 Aug; 6(8):1495-508. PubMed ID: 21674809
[TBL] [Abstract][Full Text] [Related]
7. Tetramer-dimer equilibrium of oxyhemoglobin mutants determined from auto-oxidation rates.
Griffon N; Baudin V; Dieryck W; Dumoulin A; Pagnier J; Poyart C; Marden MC
Protein Sci; 1998 Mar; 7(3):673-80. PubMed ID: 9541399
[TBL] [Abstract][Full Text] [Related]
8. A straightforward method for purification of myo-inositol 1,3,4,5,6-pentakisphosphate from avian erythrocytes for subsequent application in studies on hemoglobin allosteric effect.
Prats MT; Riera M
Anal Biochem; 1994 Sep; 221(2):335-9. PubMed ID: 7810875
[TBL] [Abstract][Full Text] [Related]
9. R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35.
Yokoyama T; Neya S; Tsuneshige A; Yonetani T; Park SY; Tame JR
J Mol Biol; 2006 Feb; 356(3):790-801. PubMed ID: 16403522
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of a high oxygen affinity species of haemoglobin (bar-headed goose haemoglobin in the oxy form).
Zhang J; Hua Z; Tame JR; Lu G; Zhang R; Gu X
J Mol Biol; 1996 Jan; 255(3):484-93. PubMed ID: 8568892
[TBL] [Abstract][Full Text] [Related]
11. PEGylation promotes hemoglobin tetramer dissociation.
Caccia D; Ronda L; Frassi R; Perrella M; Del Favero E; Bruno S; Pioselli B; Abbruzzetti S; Viappiani C; Mozzarelli A
Bioconjug Chem; 2009 Jul; 20(7):1356-66. PubMed ID: 19534518
[TBL] [Abstract][Full Text] [Related]
12. [Oxygen-dissociation properties and the regulation of the oxygen affinity of a hemoglobin polymer in the bull].
Viazova EP; Azhigirova MA; Fetisova LV; Khachatur'ian AA; Rozenberg GIa
Biull Eksp Biol Med; 1983 Feb; 95(2):50-2. PubMed ID: 6824776
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and rheodynamic properties of red blood cells crosslinked with glutaraldehyde.
Arevalo F; Bellelli A; Brancaccio A; Ippoliti R; Lendaro E; Brunori M
Biotechnol Appl Biochem; 1992 Oct; 16(2):195-200. PubMed ID: 1457053
[TBL] [Abstract][Full Text] [Related]
14. Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect.
Evans BA; Ansari AK; Kamyszek RW; Salvagno M; Welsby J; Fuller M; Welsby I
Blood Cells Mol Dis; 2021 Mar; 87():102520. PubMed ID: 33242840
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide effect on the hemoglobin-oxygen affinity.
Stepuro TL; Zinchuk VV
J Physiol Pharmacol; 2006 Mar; 57(1):29-38. PubMed ID: 16601313
[TBL] [Abstract][Full Text] [Related]
16. Bezafibrate derivatives as potent effectors of hemoglobin.
Poyart C; Marden MC; Kister J
Methods Enzymol; 1994; 232():496-513. PubMed ID: 8057877
[No Abstract] [Full Text] [Related]
17. Effect of certain hexosephosphate esters on haemoglobin affinity for oxygen.
Bageacu V; Dinu V
Physiologie; 1980; 17(2):159-62. PubMed ID: 6770387
[TBL] [Abstract][Full Text] [Related]
18. Tetrakisphosphates and bispyrophosphates of myo-inositol derivatives as allosteric effectors of human hemoglobin: Synthesis, molecular recognition, and oxygen release.
Koumbis AE; Duarte CD; Nicolau C; Lehn JM
ChemMedChem; 2011 Jan; 6(1):169-80. PubMed ID: 21154804
[TBL] [Abstract][Full Text] [Related]
19. [Physico-chemical characteristics and functional properties of membrane-bound hemoglobin].
Val'ovka TI; Nazarenko VI; Korobov VM; Velykyĭ MM
Ukr Biokhim Zh (1978); 1998; 70(6):59-63. PubMed ID: 10402650
[TBL] [Abstract][Full Text] [Related]
20. Allosteric effects on oxidative and nitrosative reactions of cell-free hemoglobins.
Bonaventura C; Henkens R; Alayash AI; Crumbliss AL
IUBMB Life; 2007; 59(8-9):498-505. PubMed ID: 17701544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
